Renguo Guan
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Systemic Treatment Patterns and Clinical Outcomes in Hepatocellular Carcinoma: A Multicenter Real-World Study from China (STAR-HCC).
Journal: JHEP reports : innovation in hepatology
Published: March 21, 2026
An Inflammation-Associated Prognostic Model for Hepatocellular Carcinoma Following Radical Resection.
Journal: Journal of hepatocellular carcinoma
Published: October 05, 2025
DLGAP5 regulates malignancy and lenvatinib sensitivity of hepatocellular carcinoma through AKT/mTOR/NF-κB pathway.
Journal: European journal of medical research
Published: August 04, 2025
Trans-Arterial Indocyanine Green Staining for Precise Anatomical Hepatectomy of Liver Segments VII and VIII.
Journal: Journal of visualized experiments : JoVE
Published: April 21, 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: September 13, 2024
Assessment of Tumor Burden Score as a Feasible and Reliable Tool for Prognosis Prediction for Hepatocellular Carcinoma Undergoing Hepatectomy: A Multicenter, Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: July 27, 2024
Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study.
Journal: International journal of surgery (London, England)
Published: May 22, 2024
Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study.
Journal: International journal of surgery (London, England)
Published: May 20, 2024
The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patients.
Journal: International immunopharmacology
Published: March 26, 2024
Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma.
Journal: British journal of cancer
Published: March 03, 2024
A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: February 23, 2024
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis.
Journal: Journal of hepatocellular carcinoma
Published: December 21, 2023
Last Updated: 09/26/2026